|
Volumn 81, Issue 2, 2002, Pages 157-161
|
Clinical evaluation of MRI in the diagnosis of borderline ovarian tumors
a a a |
Author keywords
Borderline tumor; MRI; Ovary; Tumor markers
|
Indexed keywords
CA 125 ANTIGEN;
CA 19-9 ANTIGEN;
CARCINOEMBRYONIC ANTIGEN;
GADOLINIUM PENTETATE;
SIALYL LEWIS X ANTIGEN 1;
TUMOR MARKER;
UNCLASSIFIED DRUG;
ADULT;
ARTICLE;
BLOOD LEVEL;
CLINICAL ARTICLE;
CLINICAL EXAMINATION;
CONTRAST ENHANCEMENT;
EQUIPMENT;
FEMALE;
HUMAN;
HUMAN TISSUE;
MALIGNANT NEOPLASTIC DISEASE;
NUCLEAR MAGNETIC RESONANCE IMAGING;
OVARY TUMOR;
PRIORITY JOURNAL;
ADENOCARCINOMA, MUCINOUS;
ADULT;
CARCINOEMBRYONIC ANTIGEN;
FEMALE;
GADOLINIUM DTPA;
HUMANS;
MAGNETIC RESONANCE IMAGING;
MIDDLE AGED;
NEOPLASM STAGING;
OVARIAN NEOPLASMS;
OVARIECTOMY;
POSTOPERATIVE CARE;
PREDICTIVE VALUE OF TESTS;
PREOPERATIVE CARE;
PROGNOSIS;
RADIOGRAPHIC IMAGE ENHANCEMENT;
SENSITIVITY AND SPECIFICITY;
TUMOR MARKERS, BIOLOGICAL;
|
EID: 0036129071
PISSN: 00016349
EISSN: None
Source Type: Journal
DOI: 10.1034/j.1600-0412.2002.810212.x Document Type: Article |
Times cited : (20)
|
References (18)
|